EPO Patents = 2

Forward Citations = 12

Loading Chart...

4 inventors (with patents filed for the assignee):

Andrea Marziali (16 out of 51 patents)

Joel Pel (16 out of 39 patents)

Milenko Despotovic (3 out of 3 patents)

4. Milenko Despotovic (1 out of 9 patents)

16 patents: Sort by Forward Citations

1. 12509723 - Methods of sequencing with linked fragments (2025-12-30),

2. 12454719 - Linked ligation (2025-10-28),

3. 12410466 - Linked ligation (2025-09-09),

4. 12378605 - Linked target capture (2025-08-05),

5. 12359251 - Linked target capture (2025-07-15),

6. 12344888 - Linked ligation (2025-07-01),

7. 12338493 - Linked target capture (2025-06-24),

8. 12291747 - Linked target capture (2025-05-06),

9. 12291746 - Methods of sequencing linked fragments (2025-05-06),

10. 12286671 - Linked target capture (2025-04-29),

11. 12247253 - Methods of sequencing linked fragments (2025-03-11),

12. 12098419 - Linked target capture and ligation (2024-09-24),

13. 11905556 - Linked target capture (2024-02-20),

14. 11879151 - Linked ligation (2024-01-23),

15. 11827930 - Methods of sequencing with linked fragments (2023-11-28),

Company Overview

Ncan Genomics, Inc. is a biotechnology company based in Vancouver, Canada, specializing in genomic technologies and personalized medicine. The organization focuses on developing innovative solutions for genetic analysis, enabling advancements in healthcare and research. By leveraging cutting-edge genomic sequencing and bioinformatics, Ncan aims to enhance understanding of genetic disorders and improve patient outcomes through tailored therapeutic approaches. Their commitment to research and development positions them at the forefront of the evolving genomics landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#54 in Vancouver

#929 in Canada

#37,788 in the World

Vancouver, Canada

Ncan Genomics, Inc.

Forward Citations = 12

4 inventors:

Andrea Marziali (16 out of 51 patents)

Joel Pel (16 out of 39 patents)

Milenko Despotovic (3 out of 3 patents)

4. Milenko Despotovic (1 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ncan Genomics, Inc.. Retrieved from https://idiyas.com/company/ncan-genomics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]